Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Abstract Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough therapies for type 2 diabetes mellitus (T2DM)
People with pre-existing digestive conditions (IBS, GERD, SIBO, lactose intolerance), those with diets naturally high in sulfur-containing foods, and those with certain gut microbiome compositions tend to experience more sulfur burps
Talk with your healthcare professional prior to using
PlexusDx supports this precision-wellness approach by integrating genetic insights into metabolic and peptide pathways, enabling more informed conversations with healthcare providers about which option may align with your goals
US$ 28.65
US$ 25.47
US$ 25.02
US$ 28.08
US$ 22.49
